Privi Speciality Chemicals Limited has reported robust financial performance for the fiscal year ended March 31, 2026. The company posted annual revenue of Rs. 2,455.53 crore and a net profit of Rs. 357.44 crore. Alongside the positive financial results, the Board has recommended a final dividend of Rs. 10 per equity share (100%) for the 2025-26 fiscal year, subject to shareholder approval at the upcoming 41st Annual General Meeting on August 7, 2026.
Financial Performance Overview
For the financial year ended March 31, 2026, Privi Speciality Chemicals Limited achieved total revenue of Rs. 2,455.53 crore, showing significant growth. The annual net profit stood at Rs. 357.44 crore. In the final quarter (Q4) ending March 31, 2026, the company reported revenue of Rs. 660.35 crore and a quarterly net profit of Rs. 102.71 crore, underscoring a strong finish to the fiscal year.
Dividend and Shareholders Meeting
The Board of Directors has recommended a final dividend of Rs. 10 per equity share (with a face value of Rs. 10 each) for the financial year 2025-26. The payout is subject to approval at the 41st Annual General Meeting (AGM), which is scheduled for August 7, 2026. The company has fixed July 31, 2026, as the record date to determine shareholder eligibility for the dividend.
Leadership and Governance
The company announced the re-appointment of Mr. Bhaktavatsala Rao Doppalapudi as an Executive Director (Whole-time Director) for a period of 3 years, effective from August 13, 2026, until August 12, 2029. Furthermore, the Board approved the re-appointment of M/s. Aneja Associates as Internal Auditors and M/s. Kishore Bhatia & Associates as Cost Auditors for the 2026-27 financial year, ensuring continued oversight and operational governance.
Source: BSE
